Search clinical trials for: rhPSMA-7.3 (18F)

Total 3606 results

University Hospital, Tours

Completed

PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO) (NIDeCo)

Alzheimer Disease | Mild Cognitive Impairment | Memory Complaint

France
ECOG-ACRIN Cancer Research Group

Not yet recruiting

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Glioblastoma, IDH-Wildtype
National Cancer Institute (NCI)

Enrolling by invitation

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

Prostatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Prostate Neoplasms | Prostatic Cancer

United States
Guy's and St Thomas' NHS Foundation Trust
King's College London

Not yet recruiting

Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET

Cancer | Diagnosis | Resistant Cancer | Response, Acute Phase
Assistance Publique - Hôpitaux de Paris

Recruiting

Remyelination in Multiple Sclerosis: a PET-MR Longitudinal Study Investigating Individual Profiles of Myelin Repair and the Contribution of Neuroinflammation (SMARTinMS)

Multiple Sclerosis | Inflammatory Disease

France
University College, London
Imperial College London; Cancer Research UK; National Cancer Imaging Translational...

Recruiting

[18F]FPIA PET/CT Imaging in Patients With Solid Tumours ([18F]FPIA)

Cancer | Tumor, Solid

United Kingdom
The First Affiliated Hospital of Guangzhou Medical...

Unknown

The 18F Peel-way Sheath Versus the 18F Access Sheath With a Suction-evacuation Function MPCNL for the Management of 2-5cm Size Kidney Stones

Renal Calculi

China
Washington University School of Medicine

Recruiting

Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease

Alzheimer Disease

United States
Brigham and Women's Hospital

Recruiting

Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders

Synucleinopathies | Neurodegenerative Diseases | Ataxia | sca3 | MSA - Multiple System Atrophy

United States
St. Jude Children's Research Hospital

Recruiting

Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study

Brain Tumor | Medulloblastoma

United States
Peter MacCallum Cancer Centre, Australia

Recruiting

Hepatocellular Carcinoma Imaging Using PSMA PET/CT (HepaSMART)

Hepatocellular Carcinoma

Australia
First Affiliated Hospital of Fujian Medical University

Recruiting

Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders

Neurodegenerative Disorders

China
National Cancer Institute (NCI)

Recruiting

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Prostate Cancer

United States
Northwestern University
Progenics Pharmaceuticals, Inc.

Recruiting

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

Prostate Cancer

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People

Normal Physiology

United States
University Health Network, Toronto

Active, not recruiting

PSMA PET Registry (18F-DCFPyL) (PM-PPR)

Carcinoma of Prostate

Canada
Ashok Muthukrishnan
Progenics Pharmaceuticals, Inc.

Terminated

18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer

Prostate Cancer

United States
National Institute of Mental Health (NIMH)

Completed

[18F]SF12051 for Imaging the 18-kDa Translocator Protein (TSPO) in Brain and Whole Body of Healthy Subjects

Healthy

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer

Breast Cancer

United States
Harbin Medical University

Completed

EGFR Molecular Classification In Vivo

Molecular Imaging

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
Prostate Cancer Foundation; Radiological Society of North America

Completed

Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer

Prostate Cancer

United States
University Hospital, Bordeaux

Terminated

Molecular Imaging of Inflammation With 18F-PBR06 to Identify Unstable Carotid Plaques in Patients With Stroke (PLAQINSTEP)

Stroke

France
Oriental Neurosurgery Evidence-Based-Study Team

Unknown

18F-S16 PET/CT in Healthy Volunteers and Patients With Neurodegenerative Dementia

Neurodegenerative Dementia

China
Navidea Biopharmaceuticals

Unknown

Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI) (NAV4-04)

Mild Cognitive Impairment

United States
Navidea Biopharmaceuticals

Unknown

Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease

Alzheimer Disease

United States
GlaxoSmithKline

Terminated

[18F]PBR111 and Microglial Activation in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Institute for Neurodegenerative Disorders

Completed

Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions (PBR111)

Alzheimer Disease

United States
Baptist Health South Florida
Blue Earth Diagnostics

Recruiting

Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis (CONCORDANT)

Brain Cancer | Brain Metastases

United States
VA Greater Los Angeles Healthcare System

Recruiting

18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer (PROSPYL)

Prostate Cancer

United States
Life Molecular Imaging GmbH
Life Molecular Imaging SA

Completed

Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity

Alzheimer Disease | Progressive Supranuclear Palsy

Germany
M.D. Anderson Cancer Center

Active, not recruiting

Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR

Cervical Cancer | Brain Tumor

United States
Centre for Addiction and Mental Health
McMaster University

Active, not recruiting

Microglial Activation in Inflammatory Bowel Disease

Inflammatory Bowel Diseases | Major Depressive Episode

Canada
Peter MacCallum Cancer Centre, Australia

Terminated

Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies

Squamous Cell Carcinoma

Australia
University Health Network, Toronto

Completed

18F-DCFPyL PET/CT in High-grade Epithelial Ovarian Cancer (PET HOC)

Stage IV Ovarian Cancer | Stage III Ovarian Cancer

Canada
University of Edinburgh
British Heart Foundation; Life Molecular Imaging SA

Completed

18F-GP1 PET-CT to Detect Bioprosthetic Aortic Valve Thrombosis

Aortic Valve Disease | Thrombosis Cardiac

United Kingdom
Harbin Medical University

Unknown

In Vivo EGFR Molecular Classification and Treatment Response

Molecular Imaging

China
Navidea Biopharmaceuticals

Unknown

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology

Dementia | Alzheimer's Disease

United States
AstraZeneca

Completed

To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden

Alzheimer's Disease

United States
Peking Union Medical College Hospital

Unknown

18F-FDG PET/CT for IgG4-Related Disease

Autoimmune Disease

China
National Cancer Institute (NCI)

Completed

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

Kidney Cancer | Hippel-Lindau Disease

United States
Centre Hospitalier St Anne
Roche Pharma AG

Recruiting

Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease (GliSyn)

Alzheimer Disease

France
Wuxi No. 4 People's Hospital

Unknown

Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics

Carcinoma, Bronchogenic | Lymphoma, Malignant | Breast Carcinoma | Cancer of Head and Neck | Soft Tissue Neoplasms | Tumors

China
CellSight Technologies, Inc.

Not yet recruiting

Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG

Advanced Non Small Cell Lung Cancer
First Affiliated Hospital of Zhejiang University

Not yet recruiting

18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma.

18F-HER2 PET

China
Universitaire Ziekenhuizen KU Leuven

Recruiting

In Vivo PET of Synaptic Density in Cognitive Disorders

Alzheimer Disease | Frontotemporal Degeneration | Psychiatric Disorder | Dementia With Lewy Bodies

Belgium
University of Edinburgh

Completed

PET/MR Imaging In Patients With Cardiac Amyloidosis

Cardiac Amyloidosis

United Kingdom
Center Eugene Marquis

Withdrawn

Contribution of [18F]DPA-714 PET for Grading and Exploration of the Inflammatory Microenvironment of Glioma. (INFLAGLI)

Glioma
University of California, Davis

Enrolling by invitation

PET/CT Imaging in COVID-19 Patients

COVID-19 | SARS-CoV-2 Infection

United States
GE Healthcare

Completed

A Study of Flurpiridaz (18F) Injection for PET Imaging for Assessment of MPI Quality Using HPLC and SPE Manufacturing Processes

Ischemic Heart Disease | Coronary Artery Disease (CAD)

United States
Blue Earth Diagnostics
Precision For Medicine

Completed

Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (REVELATE)

Brain Metastases

United States

Search clinical trials for: rhPSMA-7.3 (18F)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations